Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

FirstWord Pharma
firstwordpharma.com > story > 7985869

Spotlight On: Ivonescimab beats expectations to revive practice-changing hopes in NSCLC

18+ hour, 40+ min ago   (13+ words) FirstWord Pharma...

firstwordpharma.com
firstwordpharma.com > story > 7973027

Friday Five??? Novartis' stumbles spark boardroom backlash, Nodthera name drops, FDA throws wrench into Biohaven deal???and more

3+ day, 16+ hour ago   (19+ words) Friday Five – Novartis' stumbles spark boardroom backlash, Nodthera name drops, FDA throws wrench into Biohaven deal…and more firstwordpharma.com...

FirstWord Pharma
firstwordpharma.com > story > 7966708

Physician Views Results: Neurologists express cautious optimism for BTK inhibitors in MS

5+ day, 4+ hour ago   (14+ words) FirstWord Pharma...

FirstWord PHARMA
firstwordpharma.com > story > 7963831

AI analysis from Brainomix adds to evidence backing Endeavor's IPF therapy

5+ day, 20+ hour ago   (13+ words) FirstWord PHARMA...

FirstWord Pharma
firstwordpharma.com > story > 7960382

Moonwalk unveils gene silencing approach to obesity, $70M in fresh funds

6+ day, 4+ hour ago   (13+ words) FirstWord Pharma...

FirstWord Pharma
firstwordpharma.com > story > 7960102

Roivant's pulmonary hypertension drug mosliciguat scores mid-stage win

6+ day, 6+ hour ago   (10+ words) FirstWord Pharma...

firstwordpharma.com
firstwordpharma.com > story > 7958314

Vital Signs: Who's enjoying the fruits of pharma's labor?

6+ day, 23+ hour ago   (10+ words) firstwordpharma.com...

FirstWord Pharma
firstwordpharma.com > story > 7957440

Novo's hopes for ziltivekimab dwindle as two heart failure studies stopped early

1+ week, 7+ hour ago   (14+ words) FirstWord Pharma...

firstwordpharma.com
firstwordpharma.com > story > 7953711

Vital Signs: Novartis, Sanofi place their bets on SC longevity for key products

1+ week, 2+ day ago   (14+ words) firstwordpharma.com...

FirstWord Pharma
firstwordpharma.com > story > 7952422

Novartis' pelacarsen fails critical cardiovascular test

1+ week, 2+ day ago   (8+ words) FirstWord Pharma...